Gaming with non-inferiority in antibiotic stewardship

An early switch from IV to oral treatment is one of the pillars of antibiotic stewardship. Oral antibiotics are mostly cheaper, hospital stay shortens and thus also the risk of healthcare-associated infections. One problem: before we change our current practice, we must demonstrate that the new strategy is safe. The best evidence comes from a … Continue reading Gaming with non-inferiority in antibiotic stewardship

On the effects of antibiotic stewardship: I met a analysis

Yet another meta-analysis telling us that we are doing something very valuable: antibiotic stewardship (AS). Nobody wants to (or should) question that good AS is important for our patients, just as hand hygiene, being sober when working and following the latest professional developments. How nice would it be if we could reliably quantify the effects … Continue reading On the effects of antibiotic stewardship: I met a analysis

Effective stewardship: less antibiotic use and more hand hygiene

Rossana Rosa (bio below) writes a guest post, reflecting on this recent review and meta-analysis on the effectiveness of antimicrobial stewardship (AMS) programmes… The first reports on the effects of Antimicrobial Stewardship Programmess date back to the mid-90s, and the interest in them has taken off in the past decade.

Cross-specialty engagement with antimicrobial stewardship

Guest blogger Dr Tim Rawson (bio below) writes… With antimicrobial resistance taking its place alongside climate change on the global political agenda, the role of antimicrobial stewardship in healthcare has come to the forefront. Being a good steward of antibiotics goes beyond simply possessing the technical ability to maintain the effectiveness of antimicrobials. It requires … Continue reading Cross-specialty engagement with antimicrobial stewardship

Online antimicrobial stewardship course

I found out about a new free online antimicrobial stewardship course yesterday. The course is a collaboration between the the University of Dundee and the British Society for Antimicrobial Chemotherapy, and comes highly recommended. The course is designed for healthcare professionals. If anybody completes the course, I’d be interested to hear your feedback.

Antibiotic surgical prophylaxis: stewardship’s ‘elephant in the room’?

We are all pretty comfortable with the idea that we have used too many antibiotics in the past and now we are reaping the consequences. I think we are also all in agreement that we need to start using antibiotics much more rationally – and keep the big guns firmly on the top shelf, double-wrapped … Continue reading Antibiotic surgical prophylaxis: stewardship’s ‘elephant in the room’?

The role of IPC, vaccination, and OTC distribution in AMR

I had the privilege of chairing a session in the BSAC Spring Conference webinars yesterday about the role of IPC, vaccination, and OTC distribution in AMR. The session had a talk from Professor Andreas Voss on IPC as a cornerstone of successful stewardship, Dr Elizabeth Klemm on prevention through vaccination, and Dr Abdul Ghafur on … Continue reading The role of IPC, vaccination, and OTC distribution in AMR

Can we halve GNBSI? The crowd say no…!

I participated in another pro-con debate recently up against fellow Reflections blogger Martin Kiernan during a Webber Teleclass. The question for the debate was “Can we halve Gram-negative BSI?” (I was arguing that we can). We ran a live Twitter poll and the outcome: 59% of the 22 respondents voted that no, we can’t halve GNBSI.

Managing ventilation in the context of COVID-19: a HIS audience-led webinar

The next in the series of the HIS audience-led webinar on all-things ventilation in the management of COVID-19 went out recently. The panel consisted of: Peter Hoffman – Consultant Clinical Scientist, London Dr Chris Lynch – Graham Ayliffe Training Fellow, Sheffield Teaching Hospitals Professor Catherine Noakes – Professor of Environmental Engineering for Buildings, University of Leeds … Continue reading Managing ventilation in the context of COVID-19: a HIS audience-led webinar